Skip to content
    Compare notes on r/BodyHackGuideCompare notes with other researchers. Join r/BodyHackGuide

    Orforglipron vs 5-Amino-1MQ

    Side-by-side comparison of Orforglipron and 5-Amino-1MQ: mechanism, half-life, dose range, safety profile, and vendor pricing.

    Orforglipron from $249.99
    5-Amino-1MQ from $29.99

    Price snapshot

    Orforglipron

    Current low
    $249.99
    current listings
    7-day low
    —
    not enough history yet
    30-day low
    —
    not enough history yet
    30-day change
    —
    not enough history yet

    5-Amino-1MQ

    Current low
    $29.99
    current listings
    7-day low
    —
    not enough history yet
    30-day low
    —
    not enough history yet
    30-day change
    —
    not enough history yet

    Orforglipron

    Orforglipron (also known as LY3502970) is Eli Lilly's oral, non-peptide, small-molecule glucagon-like peptide-1 (GLP-1) receptor agonist, approved in the US for weight management and submitted to the FDA for type 2…

    Lowest listed price: $249.99 across 1 listing

    Full Orforglipron profile

    5-Amino-1MQ

    5-Amino-1MQ (5-amino-1-methylquinolinium iodide) is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme that transfers a methyl group from S-adenosyl-L-methionine (SAM) to nicotinamide to…

    Lowest listed price: $29.99 across 14 listings

    Full 5-Amino-1MQ profile

    Side-by-side comparison

    Attribute Orforglipron 5-Amino-1MQ
    Category Weight Loss Weight Loss
    Research Stage FDA Approved Preclinical
    Mechanism of Action Orforglipron (LY3502970; OWL833) is an oral, non-peptide (small-molecule) GLP-1 receptor agonist. It engages the GLP-1 receptor (GLP1R) through a binding mode fundamentally different from native GLP-1 or peptide-based analogs. Non-Peptide Binding at a Distinct… 5-Amino-1MQ works by inhibiting nicotinamide N-methyltransferase (NNMT), an enzyme that catalyzes the transfer of a methyl group from S-adenosyl-L-methionine (SAM) to the nitrogen of nicotinamide (vitamin B3 amide), producing 1-methylnicotinamide (1-MNA) and…
    Half-Life ~29-49 hours (supports once-daily oral dosing) ~6–12 hours (oral)
    Typical Dose Range — 50 mg - 150 mg daily (oral or injection)
    Dosing Frequency Once daily Once daily oral
    Administration — Oral
    Side Effects Orforglipron's side effect profile closely mirrors the GLP-1 receptor agonist class as a whole, dominated by gastrointestinal effects that typically improve with continued dosing and proper titration. Common Gastrointestinal Effects (incidence 20-50% depending… The side effect profile of 5-amino-1MQ in humans is not documented because there are no human clinical trials. Rodent studies report generally good tolerability at doses producing metabolic and muscle benefits, without obvious signs of hepatotoxicity,…
    Molecular Weight 882.97 g/mol 159.21 g/mol
    Common Vial Sizes — 50mg capsules, 100mg capsules

    Price tracking

    Tracking Orforglipron prices since April 6, 2026. Trend chart unlocks once we have price snapshots from more than one day.

    Price History

    5 data points
    • OF
    • BM
    • Half Nattys
    • Ion Peptide
    • Disguised Alpha
    • RC
    • LB

    Orforglipron: potential benefits

    • No structured benefit list published.

    5-Amino-1MQ: potential benefits

    • Enhanced fat metabolism and weight loss
    • Increased NAD+ levels in adipose tissue
    • Improved cellular energy production
    • Anti-aging properties via sirtuin activation

    Frequently asked

    What's the difference between Orforglipron and 5-Amino-1MQ?

    Orforglipron is a weight loss that orforglipron (ly3502970; owl833) is an oral, non-peptide (small-molecule) glp-1 receptor agonist. it engages the glp-1 receptor (glp1r) through a binding mode fundamentally…. 5-Amino-1MQ is a weight loss that 5-amino-1mq works by inhibiting nicotinamide n-methyltransferase (nnmt), an enzyme that catalyzes the transfer of a methyl group from s-adenosyl-l-methionine (sam) to the nitrogen…. The two differ in mechanism, half-life (~29-49 hours (supports once-daily oral dosing) vs ~6–12 hours (oral)), and typical dose range.

    Which has the longer half-life, Orforglipron or 5-Amino-1MQ?

    Orforglipron has a half-life of ~29-49 hours (supports once-daily oral dosing). 5-Amino-1MQ has a half-life of ~6–12 hours (oral). Longer half-lives generally mean less frequent dosing but slower on/off kinetics.

    Which is cheaper, Orforglipron or 5-Amino-1MQ?

    Lowest listed price on BodyHackGuide: Orforglipron from $249.99, 5-Amino-1MQ from $29.99. Prices are pulled from the vendor listings tracked on BHG and change frequently. See the compare tables on each compound page for the current set of offers.

    Can you stack Orforglipron and 5-Amino-1MQ?

    Stacking depends on mechanism overlap, safety profile, and goals. Orforglipron and 5-Amino-1MQ should only be stacked after reviewing each compound's individual protocol page, side effect profile, and any published interaction data. Use the BodyHackGuide stack builder for a structured review before combining research compounds.

    See current vendor prices

    Listings from the vendors we track. Prices change often, so check the vendor before you buy.

    Orforglipron prices 5-Amino-1MQ prices Compare all compounds

    Before you buy Orforglipron or 5-Amino-1MQ

    Check the vendor trust score. Every supplier we track is rated 0-100 on COA verification, payment transparency, shipping, reviews, and listings: one published, reproducible methodology, applied to every vendor.

    View Vendor Scorecard

    Related comparisons

    Orforglipron vs Semaglutide5-Amino-1MQ vs Tirzepatide

    Research use only. BodyHackGuide is a research and price-comparison reference. The compounds discussed on this page are not approved by the FDA for human consumption and are sold strictly for laboratory research. Prices shown are pulled from vendor listings tracked on BHG and are subject to change. Every vendor is ranked on the same public, reproducible methodology. See editorial standards and affiliate disclosure.